John T. Isaacs

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer”.

Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer

JCI Insight(2021)10.1172/jci.insight.146827

N/A

1.5DataRank · unranked

58 citations

Yezi Zhu, Ilsa M. Coleman, Susan L. Dalrymple, Lizamma Antony, Radhika A. Patel +16 more

Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy

European Journal of Cancer(2020)10.1016/j.ejca.2020.11.043

N/A

1.2DataRank · unranked

47 citations

Hao Wang, Su J. Lim ScM, Irina Rifkind, Nduku Ngomba, John T. Isaacs +10 more

The current state of preclinical prostate cancer animal models

UNC Libraries(2020)10.17615/kfq3-9222

N/A

0DataRank · unranked

0 citations

J.W. Simons, Terry A. VanDyke, Leland W.K. Chung, Kenneth J. Pienta, Howard R. Soule +12 more

Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer

Cancer Research(2021)10.1158/0008-5472.can-20-3607

N/A

0DataRank · unranked

48 citations

Janet Mendonca, Olutosin Owoyemi, Kavya Boyapati, Naiju Thomas, Suthicha Kanacharoen +20 more

Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling

Cancer Research(2022)10.1158/0008-5472.can-22-1533

N/A

0DataRank · unranked

22 citations

Andreas Varkaris, Peter J.P. Croucher, Maya Ridinger, Susan L. Dalrymple, Mannan Nouri +14 more

Prostate cancer androgen receptor activity dictates efficacy of Bipolar Androgen Therapy

medRxiv(2022)10.1101/2022.04.26.22274275

N/A

0DataRank · unranked

4 citations

Rajendra Kumar, David E. Sanin, Elizabeth A. Thompson, Dina Rosen, Susan L. Dalrymple +20 more

Polo-like kinase-1 Inhibitors and the Antiandrogen Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.12.491633

N/A

0DataRank · unranked

0 citations

Andreas Varkaris, Peter J.P. Croucher, Maya Ridinger, Susan L. Dalrymple, Mannan Nouri +14 more

Targeting the fibroblast growth factor pathway in molecular subtypes of castration‐resistant prostate cancer

The Prostate(2023)10.1002/pros.24630

N/A

0DataRank · unranked

12 citations

Lisha G. Brown, Ilsa M. Coleman, Holly M. Nguyen, Susan L. Dalrymple, W. Nathaniel Brennen +11 more

Third generation quinoline‐3‐carboxamide transcriptional disrupter of HDAC4, HIF‐1α, and MEF‐2 signaling for metastatic castration‐resistant prostate cancer

The Prostate(2023)10.1002/pros.24606

N/A

0DataRank · unranked

5 citations

Susan L. Dalrymple, Lizamma Antony, David M. Rosen, Ilsa M. Coleman, Peter S. Nelson +7 more

Data from Low-Calcium Serum-Free Defined Medium Selects for Growth of Normal Prostatic Epithelial Stem Cells

(2023)10.1158/0008-5472.c.6494118

N/A

0DataRank · unranked

0 citations

Donald J. Vander Griend, Yi Xu, Lizamma Antony, Susan L. Dalrymple, John T. Isaacs +1 more

Data from Low-Calcium Serum-Free Defined Medium Selects for Growth of Normal Prostatic Epithelial Stem Cells

(2023)10.1158/0008-5472.c.6494118.v1

N/A

0DataRank · unranked

0 citations

Donald J. Vander Griend, Yi Xu, Lizamma Antony, Susan L. Dalrymple, John T. Isaacs +1 more

Data from Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer

(2023)10.1158/0008-5472.c.6513589.v1

N/A

0DataRank · unranked

0 citations

Janet Mendonca, Olutosin Owoyemi, Kavya Boyapati, Naiju Thomas, Suthicha Kanacharoen +20 more

Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models

The Prostate(2024)10.1002/pros.24707

N/A

0DataRank · unranked

12 citations

Adel Mandl, Timothy Krueger, Susan L. Dalrymple, Lizamma Antony, Jennifer Dias +16 more

AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0933

N/A

0DataRank · unranked

5 citations

Andreas Varkaris, Maya Ridinger, Susan L. Dalrymple, Christopher M. Dennehy, John T. Isaacs +4 more

Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors

Oncogene(2020)10.1038/s41388-020-01479-6

N/A

0DataRank · unranked

105 citations

Susan L. Dalrymple, Ilsa M. Coleman, Shun Zheng, Jianfeng Xu, Jody E. Hooper +10 more

Androgen receptor drives polyamine synthesis creating a vulnerability for prostate cancer

medRxiv(2024)10.1101/2024.12.12.24318845

N/A

0DataRank · unranked

3 citations

Sheila Jonnatan, David E. Sanin, Varsha Vakkala, Anoushka Kadam, Shivani Kumar +20 more

Microparticle Encapsulation of a Prostate-targeted Biologic for the Treatment of Liver Metastases in a Preclinical Model of Castration-resistant Prostate Cancer

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0227

N/A

0DataRank · unranked

3 citations

Lizamma Antony, Oren Levy, Nitin Joshi, Brian W. Simons, Susan L. Dalrymple +12 more